Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Hammond

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future PerspectivesEdward Hammond, Keith Dredge
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying KineticsEdward Hammond, Vito Ferro
Medicine, Conflict, and Survival|June 5, 2002
Closing loopholes in the Biological Weapons ConventionJan van Aken, Edward Hammond
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|April 5, 2008
An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratoriesMargaret S Race, Edward Hammond
Plos One|January 10, 2013
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma modelEdward Hammond, Ralf Brandt, Keith Dredge
Mini Reviews in Medicinal Chemistry|July 29, 2004
The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammationVito Ferro, Edward Hammond, Jon K Fairweather
Analytical Biochemistry|September 15, 2009
Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screeningEdward Hammond, Cai Ping Li, Vito Ferro
Frontiers in Oncology|August 9, 2014
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer TherapeuticsEdward Hammond, Ashwani Khurana, Viji Shridhar, et al.
FEBS Open Bio|November 20, 2013
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analoguesEdward Hammond, Paul Handley, Keith Dredge, et al.
Bioorganic & Medicinal Chemistry|October 31, 2007
Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88Jon K Fairweather, Edward Hammond, Ken D Johnstone, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future PerspectivesEdward Hammond, Keith Dredge
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying KineticsEdward Hammond, Vito Ferro
Medicine, Conflict, and Survival|June 5, 2002
Closing loopholes in the Biological Weapons ConventionJan van Aken, Edward Hammond
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|April 5, 2008
An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratoriesMargaret S Race, Edward Hammond
Plos One|January 10, 2013
PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma modelEdward Hammond, Ralf Brandt, Keith Dredge
Mini Reviews in Medicinal Chemistry|July 29, 2004
The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammationVito Ferro, Edward Hammond, Jon K Fairweather
Analytical Biochemistry|September 15, 2009
Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screeningEdward Hammond, Cai Ping Li, Vito Ferro
Frontiers in Oncology|August 9, 2014
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer TherapeuticsEdward Hammond, Ashwani Khurana, Viji Shridhar, et al.
FEBS Open Bio|November 20, 2013
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analoguesEdward Hammond, Paul Handley, Keith Dredge, et al.
Bioorganic & Medicinal Chemistry|October 31, 2007
Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88Jon K Fairweather, Edward Hammond, Ken D Johnstone, et al.
Pageof 6